| (Values in U.S. Thousands) | Dec, 2015 | Dec, 2014 | Dec, 2013 | Dec, 2012 | Dec, 2011 |
| Sales | 0 | 0 | 9,140 | 6,190 | 1,730 |
| Sales Growth | unch | -100.00% | +47.66% | +257.80% | +103.53% |
| Net Income | -6,850 | -38,520 | -32,830 | -22,850 | -37,990 |
| Net Income Growth | +82.22% | -17.33% | -43.68% | +39.85% | -34.34% |
Rock Creek Pharmaceuticals Inc (RCPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Rock Creek Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for inflammatory conditions, clinical immunology, neurological disease and behavioral health. Rock Creek Pharmaceuticals, Inc., formerly known as Star Scientific, Inc., is headquartered in Sarasota, Florida.